Menu Search
Equities

Granules India Ltd

GRANULES:NSI

Granules India Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)559.50
  • Today's Change14.50 / 2.66%
  • Shares traded1.04m
  • 1 Year change+53.98%
  • Beta0.5208
Data delayed at least 15 minutes, as of Nov 22 2024 10:19 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
  • 21-Nov-24
Select bar for recommendation details.
Recommendations21-Nov-24
Buy2
Outperform2
Hold0
Sell0
Strong Sell0

Share price forecast in INR

The 4 analysts offering 12 month price targets for Granules India Ltd have a median target of 640.00, with a high estimate of 700.00 and a low estimate of 515.00. The median estimate represents a 14.49% increase from the last price of 559.00.
High25.2%700.00
Med14.5%640.00
Low-7.9%515.00

Dividends

In 2024, Granules India Ltd reported a dividend of 1.50 INR, equaling last years dividend. The analyst covering the company expects dividends of 1.00 INR for the upcoming fiscal year, a decrease of 33.33%.
Div growth (TTM)0.00%
More ▼

Earnings history & estimates in INR

On May 18, 2022, earnings of 4.46 per share.
The next earnings announcement is expected on Jan 21, 2025.
Average growth rate+2.84%
Granules India Ltd reported annual 2024 earnings of 16.72 per share on May 15, 2024.
Average growth rate+15.94%
More ▼

Revenue history & estimates in INR

Granules India Limited had 2nd quarter 2025 revenues of 9.67bn. This missed the 10.24bn consensus estimate of the 2 analysts following the company. This was 18.74% below the prior year's 2nd quarter results.
Average growth rate-4.85%
Granules India Limited had revenues for the full year 2024 of 45.06bn. This was 0.12% below the prior year's results.
Average growth rate+15.15%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.